UCFA
DFTX

United Capital Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

United Capital Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-775
Closed -$7K – 1129
2022
Q2 		$7K Sell
775
-5
-0.6% -$63 ﹤0.01% 1114
2022
Q1 		$13K Sell
780
-125
-14% -$2.17K ﹤0.01% 1154
2021
Q4 		$19K Sell
905
-100
-10% -$3.19K ﹤0.01% 1194
2021
Q3 		$35K Buy
+1,005
New +$43.4K ﹤0.01% 1189

Other funds holding DFTX

DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

United Capital Financial Advisors's DFTX Position: Q3 2022 in Review

United Capital Financial Advisors sold out of Definium Therapeutics (DFTX) in Q3 2022, closing a stake of 775 shares — an estimated $7K sold.

United Capital Financial Advisors first reported a position in DFTX in Q3 2021 and held it in 4 quarters. The position peaked at $35K in Q3 2021. 101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

  • United Capital Financial Advisors reported no remaining Definium Therapeutics position as of Q3 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 775 Definium Therapeutics shares in Q3 2022, an estimated $7K.
  • United Capital Financial Advisors first reported a position in Definium Therapeutics in Q3 2021 and held it in 4 quarters.
  • United Capital Financial Advisors's Definium Therapeutics position peaked at $35K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on United Capital Financial Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.